RU 486: an overview of mifepristone and its potential applications.
D000019:Abortifacient Agents; D000028:Abortion, Induced; D000569:Americas; D001695:Biology; D001943:Breast Neoplasms; D003267:Contraception; D003270:Contraceptive Agents; D003271:Contraceptive Agents, Female; D003281:Contraceptives, Postcoital; D019049:Developed Countries; D004194:Disease; D010064:Embryo Implantation; D004703:Endocrine System; D004717:Endometrium; D005060:Europe; D005193:Family Planning Services; D005602:France; D005835:Genitalia; D005836:Genitalia, Female; D006727:Hormone Antagonists; D006728:Hormones; D007747:Labor Stage, First; D008598:Menstruation; D015735:Mifepristone; D009369:Neoplasms; D009656:North America; D010060:Ovulation; D010827:Physiology; D013812:Therapeutics; D014481:United States; D014566:Urogenital System; D014599:Uterus
D000019:Abortifacient Agents; D003270:Contraceptive Agents; D003271:Contraceptive Agents, Female; D003281:Contraceptives, Postcoital; D006727:Hormone Antagonists; D006728:Hormones; D015735:Mifepristone
Abortifacient Agents; Abortion, Drug Induced; Abortion, Induced; Americas; Biology; Breast Cancer; Cancer; Cervical Dilatation; Contraception; Contraceptive Agents; Contraceptive Agents, Female; Contraceptive Agents, Postcoital; Contraceptive Mode Of Action; Developed Countries; Diseases; Endocrine System; Endometrial Effects; Endometrium; Europe; Family Planning; Fertility Control, Postcoital; Fertility Control, Postconception; France; Genitalia; Genitalia, Female; Hormone Antagonists; Hormones; Implantation Suppression; Literature Review; Mediterranean Countries; Menstrual Regulation; Neoplasms; North America; Northern America; Ovulation Suppression; Physiology; Ru-486--side effects; Treatment; United States; Urogenital System; Uterus; Western Europe